Literature DB >> 12707251

Prevention of cardiovascular ischemic events: high-risk and secondary prevention.

Jacques Genest1, Terje R Pedersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12707251     DOI： 10.1161/01.CIR.0000067881.26274.BD

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  The analysis by Manuel and colleagues creates controversy with headlines, not data.

Authors:  Jacques Genest; Ruth McPherson; Jiri Frohlich; George Fodor
Journal:  CMAJ       Date:  2005-04-12       Impact factor: 8.262

2.  Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Eun Hui Bae; Sang Yup Lim; Myung Ho Jeong; Hyung Wook Park; Ji Hyun Lim; Young Joon Hong; Weon Kim; Ju Han Kim; Jeong Gwan Cho; Young Keun Ahn; Jong Chun Park; Soon Pal Suh; Byoung Hee Ahn; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

Review 3.  Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease.

Authors:  Jacques Genest
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

4.  Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Authors:  Steven M Edworthy; Bonnie Baptie; Donna Galvin; Rollin F Brant; Terry Churchill-Smith; Dante Manyari; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

5.  Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina.

Authors:  Kyoung-Ha Park; Sang Jin Han; Hyun-Sook Kim; Min-Kyu Kim; Sang Ho Jo; Sung-Ai Kim; Woo Jung Park
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

6.  Sphingomyelin phosphodiesterase-1 (SMPD1) coding variants do not contribute to low levels of high-density lipoprotein cholesterol.

Authors:  Zari Dastani; Isabelle L Ruel; James C Engert; Jacques Genest; Michel Marcil
Journal:  BMC Med Genet       Date:  2007-12-18       Impact factor: 2.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.